Skip to main content

Tweets

Arthritis & Rheumatology has published a new study that suggests knee or hip osteoarthritis patients who are overweight or obese may have less premature death if slow to moderate rate of weight loss results from anti-obesity medications. https://t.co/eSwcybRmX5 https://t.co/xEzMwIvAsK
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
ICYMI: Who gives a ‘JAK’ why and how they work, as long as they do! https://t.co/dXp0bDlnMW https://t.co/k0Jl7EX6zt
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
Subtype of dermatomyositis is positive for Melanoma differentiation-associated protein 5 (MDA5) antibody. This poor prognosis subtype has distinctive rashes, rapidly progressive interstitial lung disease, lymphopenia &elevated ferritin levels https://t.co/30S4si0Luy https://t.co/xlEVEJMoSp
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
Cardiac Troponin T and MACE Events in RA Dr. Arthur Kavanaugh discusses abstract 0387 at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/6ZcIQzsv4n https://t.co/34fFk3HTWy
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
According to AAMC, clinical neurophysiology has lowest (0.8) number of MDs/100K, while pediatrics has the highest (59.5). In a list of 52, Rheumatology is #17 at mean of 2 Rheums per 100,000 population https://t.co/BrrfSIeHb9 https://t.co/69kRSlk9Dq
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
ICYMI: The Fallacy of Biologic Treatment to Prevent Rheumatoid Arthritis The window of opportunity concept in RA then shifted our focus to trying to treat disease earlier and more aggressively to improve long term outcomes. https://t.co/NTjYbMJJb6 https://t.co/TYuY1Q11xZ
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
Venous Thromboembolic Risk with Joint Replacement Save A recent study suggests that thromboprophylaxis strategies should be tailored to individual risk of thrombosis and bleeding. https://t.co/FKOsNkWMqz https://t.co/XH4SiQ735g
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
ICYMI: New Biomarkers and Therapeutics Show Potential in Still's Disease AOSD is a rare complex, sporadic, systemic autoinflammatory disease similar to sJIA characterized by sustained fever, salmon-colored rash, and arthritis . https://t.co/ZU0XFecPyP https://t.co/GLPsf73Hj0
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
Kuwait #RA registry study - shows in RA, the Uric acid level is inversely proportional to RA disease activity. 1054 RA pts, 15% had high UA level; lower DAS28 score associated w/ higher UA (p=0.032) OR 1.39; but higher HAQ assoc w/ higher UA https://t.co/muN0BFDs2Z https://t.co/VMdCgGPwPB
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
Early bird pricing has been extended! Register today! https://t.co/xvGZgXxRs8 https://t.co/kiXk3TEvnD
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
Palmoplantar pustulosis (PPP) is difficult to treat; w/ few reports of JAKi efficacy. Now a report of 21 PPP pts given bimekizumab and 17 patients showed complete clearance in 1 to 4 months. SAPHO pts had complete clearance of skin & improved joint pain https://t.co/aHEiXZJGD8 https://t.co/QOuf8nsBXW
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
UK Dermatology Registry of 13 699 Psoriasis pts on biologics (25K biologic exposures) found 1% risk of paradoxical eczema. Biologics included inhibitors of TNF, IL-17, IL12/23, IL-23. Lowest risk w/ IL-23i (0.56/100kPY), and higher w/ IL-17i (1.22) https://t.co/SorkOl5G0J https://t.co/msNSJ0l9M4
Dr. John Cush @RheumNow ( View Tweet )
2 years 6 months ago
×